由于维生素B12缺乏而导致的非免疫血清性贫血-A病例报告
Ashish Tamang1, Prakash Sapkota2, Ram Bahadur Gurung2
1Kathmandu University School of Medical Sciences Dhulikhel Hospital Dhulikhel Nepal.
Clinical case reports
|October 28, 2024
概括
维生素B12缺乏会导致非免疫性溶血性贫血,这是一个罕见但可治疗的疾病. 早期诊断和补充维生素B12 (可巴胺) 对于有效的患者管理和改善结果至关重要.
科学领域:
- 血液学 血液学 血液学
- 营养科学 营养科学
- 内部医学 内部医学
背景情况:
- 溶血性贫血是一种红细胞被破坏的速度比它们的生成速度快.
- 维生素B12缺乏通常与神经和血液学异常有关,但其在溶血性贫血中的作用不太常见.
研究的目的:
- 强调在对非免疫血清性贫血的差异诊断中考虑维生素B12缺乏的重要性.
- 介绍一个案例,说明严重的维生素B12缺乏和血液溶解性贫血之间的联系.
主要方法:
- 病例报告详细介绍了一个患有不明原因的溶血性贫血的患者.
- 对诊断工作的审查,包括维生素B12水平和周围血液涂抹.
- 在补充维生素B12后对血液学参数的监测.
主要成果:
- 患者呈现出非免疫性血液溶解性贫血.
- 严重的维生素B12缺乏被确定为潜在原因.
- 血液溶解在开始维生素B12 (科巴胺) 治疗后完全消失.
结论:
- 维生素B12缺乏是非免疫血清性贫血的一个不常见但重要的原因.
- 早期识别和治疗维生素B12缺乏症可以使血液溶解性贫血完全恢复.
- 全面的诊断评估对于确定可治疗的血液溶解原因至关重要.
相关概念视频
Blood Transfusion and Agglutination
13.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.1K
Disorders of Erythrocytes
2.7K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Vitamins
2.7K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.7K
Hypersensitivity Reactions: Cytolytic Reactions
221
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
221


